2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid

C42H52F5N7O8 — CID 145216222

IUPAC2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid
SMILESCC(C(=O)NCCCCCCNC(=O)C(N)CCN(C(=O)CO)C(c1nc(-c2cc(F)ccc2F)cn1Cc1ccccc1)C(C)(C)C)N1C(=O)C=CC1=O.O=C(O)C(F)(F)F
InChIInChI=1S/C40H51F2N7O6.C2HF3O2/c1-26(49-33(51)16-17-34(49)52)38(54)44-19-10-5-6-11-20-45-39(55)31(43)18-21-48(35(53)25-50)36(40(2,3)4)37-46-32(29-22-28(41)14-15-30(29)42)24-47(37)23-27-12-8-7-9-13-27;3-2(4,5)1(6)7/h7-9,12-17,22,24,26,31,36,50H,5-6,10-11,18-21,23,25,43H2,1-4H3,(H,44,54)(H,45,55);(H,6,7)
InChIKeyRDEJGEMFZNKQHT-UHFFFAOYSA-N
MW877.91 g/mol
LogP4.24
Rot. Bonds19

About 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid

2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid (PubChem CID 145216222) has the molecular formula C42H52F5N7O8 and a molecular weight of 877.91 g/mol. Its IUPAC name is 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid.

Molecular Properties

Compound Name2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid
PubChem CID145216222
Molecular FormulaC42H52F5N7O8
Molecular Weight877.91 g/mol
Exact Mass877.38
IUPAC Name2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid
SMILESCC(C(=O)NCCCCCCNC(=O)C(N)CCN(C(=O)CO)C(c1nc(-c2cc(F)ccc2F)cn1Cc1ccccc1)C(C)(C)C)N1C(=O)C=CC1=O.O=C(O)C(F)(F)F
InChIInChI=1S/C40H51F2N7O6.C2HF3O2/c1-26(49-33(51)16-17-34(49)52)38(54)44-19-10-5-6-11-20-45-39(55)31(43)18-21-48(35(53)25-50)36(40(2,3)4)37-46-32(29-22-28(41)14-15-30(29)42)24-47(37)23-27-12-8-7-9-13-27;3-2(4,5)1(6)7/h7-9,12-17,22,24,26,31,36,50H,5-6,10-11,18-21,23,25,43H2,1-4H3,(H,44,54)(H,45,55);(H,6,7)
InChIKeyRDEJGEMFZNKQHT-UHFFFAOYSA-N
XLogP4.24
TPSA217.26 Ų
H-Bond Donors5
H-Bond Acceptors10
Rotatable Bonds19
Heavy Atoms62
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500877.91
LogP ≤ 54.24
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid?
The IUPAC name of 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid (CID 145216222) is 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid.
What is the SMILES notation for 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid?
The canonical SMILES for 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid is CC(C(=O)NCCCCCCNC(=O)C(N)CCN(C(=O)CO)C(c1nc(-c2cc(F)ccc2F)cn1Cc1ccccc1)C(C)(C)C)N1C(=O)C=CC1=O.O=C(O)C(F)(F)F.
What is the InChIKey of 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid?
The InChIKey is RDEJGEMFZNKQHT-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H51F2N7O6.C2HF3O2/c1-26(49-33(51)16-17-34(49)52)38(54)44-19-10-5-6-11-20-45-39(55)31(43)18-21-48(35(53)25-50)36(40(2,3)4)37-46-32(29-22-28(41)14-15-30(29)42)24-47(37)23-27-12-8-7-9-13-27;3-2(4,5)1(6)7/h7-9,12-17,22,24,26,31,36,50H,5-6,10-11,18-21,23,25,43H2,1-4H3,(H,44,54)(H,45,55);(H,6,7).
What are the key properties of 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid?
2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid has a molecular weight of 877.91 g/mol, XLogP of 4.24, 19 rotatable bonds, 5 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-4-[[1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-(2-hydroxyacetyl)amino]-N-[6-[2-(2,5-dioxopyrrol-1-yl)propanoylamino]hexyl]butanamide;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 145216222), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).